4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-014438
Director sold 5,631 shares at $24.02 ($135,228)
- Director acquired 5,631 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gould Robert J Director | 2022-04-07 | Option exercise | +5,631 | $7.84 | $44,147 | 512,261 | D |
| Gould Robert J Director | 2022-04-07 | Sale | −5,631 | $24.02 | $135,228 | 506,630 | D |
| Derivatives | |||||||
| Gould Robert J Director | 2022-04-07 | Option exercise · Stock Option (right to buy) | −5,631 | 224,580 | D | ||
| Open-market sales · 5,631 sh · avg $24.02 · $135,228 | |||||||
Loading xslF345X03/doc4.xml…